WELCOME TO THE
SERVIER UK WEBSITE

More information about Servier Group

21,400

employees

150

countries in which
the Group’s medicines
are distributed

20%

Over 20% of revenue from
brand-name medicines invested
in R&D each year

€ 4.9 billion

euros in revenue in 2021/2022
including €3.7 billion for brand-name medicines and
€1.2 billion for generic activities

4 therapeutic areas

Oncology, Neuroscience,
Immuno-inflammation,
Cardiometabolism

Posts on our social networks

OUR COMMITMENTS

At Servier, we believe that providing future generations with a healthier world is the very essence of our mission. As a leading pharmaceutical company, we work towards our purpose with passion, dedication, and determination.

First and foremost, our conviction embodies patient-centricity, as well as supporting healthcare professionals and the NHS, compliance and our corporate social responsibility.

CLINICAL TRIALS